161 related articles for article (PubMed ID: 2516841)
1. Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.
Ishizaka Y; Itoh F; Tahira T; Ikeda I; Ogura T; Sugimura T; Nagao M
Jpn J Cancer Res; 1989 Dec; 80(12):1149-52. PubMed ID: 2516841
[TBL] [Abstract][Full Text] [Related]
2. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
4. Proto-RET is rearranged in the new human papillary thyroid cancer cell line PTC-1113A.
Herrmann ME
Cancer Genet Cytogenet; 1996 Jul; 89(1):14-20. PubMed ID: 8689603
[TBL] [Abstract][Full Text] [Related]
5. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.
Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M
Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030
[TBL] [Abstract][Full Text] [Related]
6. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
[TBL] [Abstract][Full Text] [Related]
7. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
8. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.
Tahira T; Ishizaka Y; Itoh F; Sugimura T; Nagao M
Oncogene; 1990 Jan; 5(1):97-102. PubMed ID: 2181380
[TBL] [Abstract][Full Text] [Related]
10. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
Lam KY; Lo CY; Leung PS
Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
[TBL] [Abstract][Full Text] [Related]
12. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
13. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.
Zou M; Shi Y; Farid NR
Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421
[TBL] [Abstract][Full Text] [Related]
14. Detection of the PTC/retTPC oncogene in human thyroid cancers.
Jhiang SM; Caruso DR; Gilmore E; Ishizaka Y; Tahira T; Nagao M; Chiu IM; Mazzaferri EL
Oncogene; 1992 Jul; 7(7):1331-7. PubMed ID: 1620547
[TBL] [Abstract][Full Text] [Related]
15. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
Ikeda I; Ishizaka Y; Tahira T; Suzuki T; Onda M; Sugimura T; Nagao M
Oncogene; 1990 Sep; 5(9):1291-6. PubMed ID: 2216455
[TBL] [Abstract][Full Text] [Related]
16. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
[TBL] [Abstract][Full Text] [Related]
17. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
[TBL] [Abstract][Full Text] [Related]
18. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
Salassidis K; Bruch J; Zitzelsberger H; Lengfelder E; Kellerer AM; Bauchinger M
Cancer Res; 2000 Jun; 60(11):2786-9. PubMed ID: 10850414
[TBL] [Abstract][Full Text] [Related]
19. Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization.
Corvi R; Martinez-Alfaro M; Harach HR; Zini M; Papotti M; Romeo G
Lab Invest; 2001 Dec; 81(12):1639-45. PubMed ID: 11742034
[TBL] [Abstract][Full Text] [Related]
20. Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue.
Bounacer A; Du Villard JA; Wicker R; Caillou B; Schlumberger M; Sarasin A; Suárez HG
Br J Cancer; 2002 Jun; 86(12):1929-36. PubMed ID: 12085189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]